Yeah sure I don't disagree. 434 for FA would be in very different position to the Reata one, but as 434 would of shown its well tolerated in sick patients already, and ready for phase 2, it could still feed into the investment case somewhat. Cheers.
- Forums
- ASX - By Stock
- ATH
- Ann: Alterity Presents Data Describing Neuroprotection of ATH434
ATH
alterity therapeutics limited
Add to My Watchlist
0.00%
!
1.1¢

Ann: Alterity Presents Data Describing Neuroprotection of ATH434, page-15
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $45.25K | 4.114M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 11296464 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 7952306 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 11296464 | 0.010 |
30 | 26711594 | 0.009 |
16 | 29340963 | 0.008 |
13 | 24058106 | 0.007 |
16 | 24953519 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 7952306 | 5 |
0.012 | 23518818 | 32 |
0.013 | 7780040 | 15 |
0.014 | 13313180 | 8 |
0.015 | 2059976 | 9 |
Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |